Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
5Y CAGR+147.9%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

5Y CAGR
+147.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
93.5x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$4.58M+38.2%
2024$3.32M-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$49000.00-59.6%
2019$121326.00+646.1%
2018$16261.00-
2017$0.00-
2016$0.00-